Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

References for PMC Articles for PubMed (Select 16683867)

1.

Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys.

Nanda A, Lynch DM, Goudsmit J, Lemckert AA, Ewald BA, Sumida SM, Truitt DM, Abbink P, Kishko MG, Gorgone DA, Lifton MA, Shen L, Carville A, Mansfield KG, Havenga MJ, Barouch DH.

J Virol. 2005 Nov;79(22):14161-8.

2.

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

Jones SM, Feldmann H, Ströher U, Geisbert JB, Fernando L, Grolla A, Klenk HD, Sullivan NJ, Volchkov VE, Fritz EA, Daddario KM, Hensley LE, Jahrling PB, Geisbert TW.

Nat Med. 2005 Jul;11(7):786-90. Epub 2005 Jun 5.

PMID:
15937495
3.

Comprehensive analysis of ebola virus GP1 in viral entry.

Manicassamy B, Wang J, Jiang H, Rong L.

J Virol. 2005 Apr;79(8):4793-805.

4.

Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway.

Sullivan NJ, Peterson M, Yang ZY, Kong WP, Duckers H, Nabel E, Nabel GJ.

J Virol. 2005 Jan;79(1):547-53.

5.

Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).

Prevots DR, Burr RK, Sutter RW, Murphy TV; Advisory Committee on Immunization Practices.

MMWR Recomm Rep. 2000 May 9;49(RR-5):1-22; quiz CE1-7.

6.
7.

Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ.

Am J Pathol. 2003 Dec;163(6):2347-70.

8.

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.

Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang ZY, Roederer M, Koup RA, Jahrling PB, Nabel GJ.

Nature. 2003 Aug 7;424(6949):681-4.

PMID:
12904795
9.

Improved adenovirus vectors for infection of cardiovascular tissues.

Havenga MJ, Lemckert AA, Grimbergen JM, Vogels R, Huisman LG, Valerio D, Bout A, Quax PH.

J Virol. 2001 Apr;75(7):3335-42. Erratum in: J Virol 2001 Jun;75(11):5440.

11.

Development of a preventive vaccine for Ebola virus infection in primates.

Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ.

Nature. 2000 Nov 30;408(6812):605-9.

PMID:
11117750
12.

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

Takada A, Watanabe S, Ito H, Okazaki K, Kida H, Kawaoka Y.

Virology. 2000 Dec 5;278(1):20-6.

13.
14.

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.

Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ.

Nat Med. 2000 Aug;6(8):886-9.

PMID:
10932225
15.

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.

Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debré P, Fisher-Hoch SP, McCormick JB, Georges AJ.

Nat Med. 1999 Apr;5(4):423-6.

PMID:
10202932
16.

Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis.

Waldrop SL, Davis KA, Maino VC, Picker LJ.

J Immunol. 1998 Nov 15;161(10):5284-95.

17.

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

Fallaux FJ, Bout A, van der Velde I, van den Wollenberg DJ, Hehir KM, Keegan J, Auger C, Cramer SJ, van Ormondt H, van der Eb AJ, Valerio D, Hoeben RC.

Hum Gene Ther. 1998 Sep 1;9(13):1909-17.

PMID:
9741429
18.

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus.

Sanchez A, Yang ZY, Xu L, Nabel GJ, Crews T, Peters CJ.

J Virol. 1998 Aug;72(8):6442-7.

19.

Immunization for Ebola virus infection.

Xu L, Sanchez A, Yang Z, Zaki SR, Nabel EG, Nichol ST, Nabel GJ.

Nat Med. 1998 Jan;4(1):37-42.

PMID:
9427604
20.

Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles.

Shabram PW, Giroux DD, Goudreau AM, Gregory RJ, Horn MT, Huyghe BG, Liu X, Nunnally MH, Sugarman BJ, Sutjipto S.

Hum Gene Ther. 1997 Mar 1;8(4):453-65.

PMID:
9054520
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk